Tara Mahon, PhD

Associate Director, Research - Protein Science Pip at Immunocore

Speaker

Tara M. Mahon is an Associate Director (Drug Discovery, Immunocore), where she leads efforts to engineer bispecific molecules to achieve targeted immune suppression to treat autoimmune and inflammatory diseases.

She joined Immunocore, (formally Avidex), contributing to fundamental research and key publications on the soluble, high affinity T cell receptor (TCR) based platform, ImmTAC (Immune modulating monoclonal TCR against cancer). Her contributions led to the approval of the first soluble TCR-based T cell engager, Tebentafusp. Recently her team developed a new class of targeted PD-1 agonist bispecific molecules to potentially treat type 1 diabetes and inflammatory skin diseases. Dr. Mahon holds a degree and PhD from Trinity College Dublin (lreland).